This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fernandez-Real, J.-M. Articles by Ricart, W. Search for Related Content PubMed PubMed Citation Articles by Fernandez-Real, J.-M. Articles by Ricart, W.

Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study

Unitat de Diabetologia, Endocrinologia i Nutricio, University Hospital of Girona, Dr. Josep Trueta, 17007 Girona, Spain; Laboratoire de la Fédération d’Endocrinologie, Hôpital de l’Antiquaille, Hospices Civils de Lyon, and INSERM, U-329, 69321 Lyon, France; and Unitat d’Endocrinologia, Hospital of Tarragona Joan XXIII, Facultat Medicina, Institut d’Estudis Avançats, Universitat Rovira i Virgili, 43007 Tarragona, Spain

Address all correspondence and requests for reprints to: J. M. Fernandez-Real, M.D., Ph.D., Unitat de Diabetologia, Endocrinologia i Nutricio, University Hospital of Girona Dr. Josep Trueta, Carretera de França s/n, 17007 Girona, Spain. E-mail: endocrino{at}htrueta.scs.es.

Abstract

It has been suggested that a low grade inflammatory state could predispose for developing insulin resistance and contribute to the development of obesity and type 2 diabetes. Corticosteroid-binding globulin (CBG), the main plasma protein transport for cortisol, has been shown to be negatively regulated by insulin and IL-6, at least in vitro, suggesting that insulin resistance and inflammation may both contribute to decreasing CBG levels. In the present study we measured CBG concentrations in a human healthy population and investigated the relationships of CBG with anthropometric and biochemical markers for inflammation and/or insulin resistance.

The data showed that the mean serum CBG level was significantly lower in males (n = 151) than in females (n = 113; 32.5 ± 9.1 vs. 39.2 ± 13.9 mg/liter; P < 0.0001). In both sexes serum CBG levels were correlated negatively with age (r = -0.12; P = 0.04), body mass index (r = -0.31; P < 0.0001), waist to hip ratio (WHR; r = -0.39; P < 0.0001), systolic (r = -0.15; P < 0.01) and diastolic (r = -0.15; P = 0.01) blood pressures, and HOMA, an index of insulin resistance (r = -0.12; P = 0.04). In addition, the CBG concentration was negatively associated with serum IL-6 concentrations (r = -0.23; P = 0.017) and with the soluble fraction of TNF receptors, soluble TNF receptor 1 (sTNFR1; r = -0.35; P < 0.0001), and sTNFR2 (r = -0.56; P < 0.0001) in women. A stepwise regression analysis using CBG as an independent variable showed that sex (P < 0.00001), body mass index (P = 0.0002), and HOMA (P = 0.0005), but not systolic blood pressure, diastolic blood pressure, IL-6, sTNFR1, or sTNFR2, constituted significant independent factors that explained 21% of the CBG variance (14%, 2%, and 5%, respectively).

In a subsample of 120 men and 68 women, fasting serum free cortisol (calculated as the ratio fasting cortisol/CBG) was significantly associated with WHR (r = 0.24; P = 0.001), systolic (r = 0.18; P = 0.01) and diastolic (r = 0.19; P = 0.007) blood pressures, and HOMA value (r = 0.20; P = 0.005), but not with BMI or age.

BMI (P < 0.0001), free cortisol (P = 0.003), and CBG (P = 0.009), but not WHR and age, contributed to 20%, 6%, and 8%, respectively, of HOMA variance in women in a multiple regression analysis. In this model only BMI (P < 0.0001) independently contributed to HOMA variance in men.

These findings support the hypothesis that the CBG level is an interesting indicator for both insulin resistance and low grade inflammation. Whether the decrease in CBG levels is genetic by nature or directly associated to increased insulin and/or IL-6 merits further investigation. Nevertheless, because CBG has been shown to be expressed by the adipose tissue, decreased CBG could create locally increased cortisol disposal, with no change in circulating cortisol, and facilitate fat accumulation, insulin resistance, and type 2 diabetes.

This article has been cited by other articles:

				D. L. Batista, N. Courcoutsakis, J. Riar, M. F. Keil, and C. A. Stratakis Severe Obesity Confounds the Interpretation of Low-Dose Dexamethasone Test Combined with the Administration of Ovine Corticotrophin-Releasing Hormone in Childhood Cushing Syndrome J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4323 - 4330. [Abstract] [Full Text] [PDF]

				D. Qi and B. Rodrigues Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667. [Abstract] [Full Text] [PDF]

				H. H. Petersen, T. K. Andreassen, T. Breiderhoff, J. H. Brasen, H. Schulz, V. Gross, H.-J. Grone, A. Nykjaer, and T. E. Willnow Hyporesponsiveness to glucocorticoids in mice genetically deficient for the corticosteroid binding globulin. Mol. Cell. Biol., October 1, 2006; 26(19): 7236 - 7245. [Abstract] [Full Text] [PDF]

				V. Guyonnet-Duperat, N. Geverink, G. S. Plastow, G. Evans, O. Ousova, C. Croisetiere, A. Foury, E. Richard, P. Mormede, and M.-P. Moisan Functional Implication of an Arg307Gly Substitution in Corticosteroid-Binding Globulin, a Candidate Gene for a Quantitative Trait Locus Associated With Cortisol Variability and Obesity in Pig Genetics, August 1, 2006; 173(4): 2143 - 2149. [Abstract] [Full Text] [PDF]

				J. T. Ho, H. Al-Musalhi, M. J. Chapman, T. Quach, P. D. Thomas, C. J. Bagley, J. G. Lewis, and D. J. Torpy Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 105 - 114. [Abstract] [Full Text] [PDF]

				L. M. Kurina, L. A. Weiss, S. W. Graves, R. Parry, G. H. Williams, M. Abney, and C. Ober Sex Differences in the Genetic Basis of Morning Serum Cortisol Levels: Genome-Wide Screen Identifies Two Novel Loci Specific to Women J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4747 - 4752. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real, A. Lopez-Bermejo, M. Broch, J. Vendrell, C. Richart, and W. Ricart Circulating Soluble CD14 Monocyte Receptor Is Associated with Increased Alanine Aminotransferase Clin. Chem., August 1, 2004; 50(8): 1456 - 1458. [Full Text] [PDF]

				O. Ousova, V. Guyonnet-Duperat, N. Iannuccelli, J.-P. Bidanel, D. Milan, C. Genet, B. Llamas, M. Yerle, J. Gellin, P. Chardon, et al. Corticosteroid Binding Globulin: A New Target for Cortisol-Driven Obesity Mol. Endocrinol., July 1, 2004; 18(7): 1687 - 1696. [Abstract] [Full Text] [PDF]

				S. Ten and N. Maclaren Insulin Resistance Syndrome in Children J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2526 - 2539. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]